• HOME
  • NEWS
  • EXPLORE
    • CAREER
      • Companies
      • Jobs
    • EVENTS
    • iGEM
      • News
      • Team
    • PHOTOS
    • VIDEO
    • WIKI
  • BLOG
  • COMMUNITY
    • FACEBOOK
    • INSTAGRAM
    • TWITTER
Friday, October 30, 2026
BIOENGINEER.ORG
No Result
View All Result
  • Login
  • HOME
  • NEWS
  • EXPLORE
    • CAREER
      • Companies
      • Jobs
        • Lecturer
        • PhD Studentship
        • Postdoc
        • Research Assistant
    • EVENTS
    • iGEM
      • News
      • Team
    • PHOTOS
    • VIDEO
    • WIKI
  • BLOG
  • COMMUNITY
    • FACEBOOK
    • INSTAGRAM
    • TWITTER
  • HOME
  • NEWS
  • EXPLORE
    • CAREER
      • Companies
      • Jobs
        • Lecturer
        • PhD Studentship
        • Postdoc
        • Research Assistant
    • EVENTS
    • iGEM
      • News
      • Team
    • PHOTOS
    • VIDEO
    • WIKI
  • BLOG
  • COMMUNITY
    • FACEBOOK
    • INSTAGRAM
    • TWITTER
No Result
View All Result
Bioengineer.org
No Result
View All Result
Home NEWS Science News Health

Lifestyle CHANGE Protocol Quadruples Metabolic Syndrome Reversal in Primary Care Trial

by
October 29, 2026
in Health
Reading Time: 3 mins read
0
Lifestyle CHANGE Protocol Quadruples Metabolic Syndrome Reversal in Primary Care Trial

Lifestyle CHANGE Protocol Quadruples Metabolic Syndrome Reversal in Primary Care Trial

Share on FacebookShare on TwitterShare on LinkedinShare on RedditShare on Telegram

A large cluster randomized controlled trial conducted in Alberta, Canada, found that adults with metabolic syndrome who completed a personalized diet and exercise program were four times more likely to reverse the condition within a year than patients receiving usual primary care. The study, published in BMC Primary Care, tested the Canadian Health Advanced by Nutrition and Grade Exercise (CHANGE) Protocol in everyday primary care settings rather than specialized research clinics.

Metabolic syndrome is a cluster of risk factors that includes dyslipidemia, elevated glucose and triglycerides, high blood pressure, and excess abdominal fat. Together, these abnormalities substantially increase the likelihood of developing cardiovascular disease and type 2 diabetes. The condition is clinically important because it typically precedes diabetes and cardiovascular disease by several years, creating a window in which progression can often be delayed or prevented through dietary changes and regular physical activity.

The trial ran from June 2016 to January 2023 and enrolled 750 participants with metabolic syndrome across 16 primary care sites. Of these, 674 participants were randomized by site into either the intervention group, which received the CHANGE Protocol, or a control group receiving usual care. Because the intervention involved lifestyle counseling, blinding of participants and providers was not possible. The registered trial identifier is NCT02893163, registered on 8 September 2016.

The primary outcome was reversal of metabolic syndrome, defined as no longer meeting at least three of the five diagnostic criteria, measured at 12 months. All five criteria were assessed before and after the intervention at each site. Eight sites, covering 320 patients, were assigned to the intervention, while eight sites with 354 patients served as the usual-care control group.

To analyze the results, the researchers used a logistic regression model that accounted for age, gender, group assignment, and baseline severity of metabolic syndrome. Patients who completed the intervention were four times more likely to reverse their metabolic syndrome than those in the control group. The model also revealed a striking pattern related to disease severity at the start of the study.

Participants who met only three of the five metabolic syndrome criteria at baseline were nearly 20 times more likely to reverse the condition compared with those meeting more criteria. This suggests that people earlier in the progression of the syndrome, with fewer risk factors to normalize, had the greatest chance of returning to a healthier metabolic profile within the trial period.

The authors conclude that the CHANGE Protocol was associated with higher rates of metabolic syndrome reversal than usual care, highlighting the potential value of early lifestyle intervention delivered where patients already receive routine medical care. They propose that the protocol could serve as a potential foundation for a broader approach they describe as "Metabolic Rehabilitation," similar to established cardiac rehabilitation programs.

Several limitations shape how these findings should be interpreted. The cluster design randomized sites rather than individuals, blinding was impossible given the nature of the intervention, and the reported association between the protocol and reversal does not by itself establish which components of the multi-part program drove the effect. The results come from primary care settings in one Canadian province, so generalization to other health systems and populations will require further study.

For clinicians, the headline result is straightforward: among patients who completed the program, the odds of no longer meeting the diagnostic threshold for metabolic syndrome at one year were roughly four times those of usual care, and the benefit appeared greatest for patients who entered with fewer criteria. For health systems weighing whether to fund structured lifestyle counseling in primary care, the trial offers a template, and the authors' proposed Metabolic Rehabilitation framework a potential foundation for a broader approach.

Subject of Research: Effectiveness of the CHANGE Protocol diet and exercise intervention for reversing metabolic syndrome in primary care

Article Title: Assessing the change protocol to treat metabolic syndrome: a cluster randomized controlled trial

Article References: Klein, D., Radil, A. I., Brauer, P., Tremblay, A., Svrcek, C., Jeejeebhoy, K., Collins, L., Al Harmaneh, Y. N., & Pan, B. (2026). Assessing the change protocol to treat metabolic syndrome: a cluster randomized controlled trial. BMC Primary Care. https://doi.org/10.1186/s12875-026-03618-6

Image Credits: AI Generated

DOI: 10.1186/s12875-026-03618-6

Keywords: metabolic syndrome, cluster randomized controlled trial, CHANGE Protocol, primary care, lifestyle intervention, diet and exercise, cardiovascular risk, diabetes prevention, Alberta, BMC Primary Care, Assessing, change

News Source: Ophelia Keating. (October 29, 2026). Lifestyle CHANGE Protocol Quadruples Metabolic Syndrome Reversal in Primary Care Trial. Scienmag.

Tags: AlbertaAssessingBMC Primary Carecardiovascular riskchangeCHANGE ProtocolCluster randomized controlled trialdiabetes preventiondiet and exerciselifestyle interventionmetabolic syndromeprimary care
Share12Tweet7Share2ShareShareShare1

Related Posts

Newly isolated feline coronavirus strain AH2023 proves lethal in cats

Newly isolated feline coronavirus strain AH2023 proves lethal in cats

October 30, 2026
Study reveals how VAV2 fuels glycolysis in esophageal squamous cell carcinoma

Study reveals how VAV2 fuels glycolysis in esophageal squamous cell carcinoma

October 30, 2026

Simple notch check guides ACL graft tunnel within a millimetre on 3D imaging

October 30, 2026

Ozone bubble water curbs guava anthracnose and slows fruit ripening

October 30, 2026

POPULAR NEWS

  • Scientists Map Regulatory DNA Behind Pig Body Size and Sharpen Genomic Prediction

    Scientists Map Regulatory DNA Behind Pig Body Size and Sharpen Genomic Prediction

    29 shares
    Share 12 Tweet 7
  • Rice Husk Waste Turned Into Chitosan Films That Shield Cherry Tomatoes

    29 shares
    Share 12 Tweet 7
  • Trust in government boosts perceived renewable energy benefits but fuels frustration

    29 shares
    Share 12 Tweet 7
  • Ferulic Acid Niosomes Shield Rat Testes from Chemotherapy Damage in Preclinical Study

    29 shares
    Share 12 Tweet 7

About

We bring you the latest biotechnology news from best research centers and universities around the world. Check our website.

Follow us

Recent News

Newly isolated feline coronavirus strain AH2023 proves lethal in cats

Fashion AI tool swaps prompt writing for structured attribute selection

Long non-coding RNA TMPO-AS1 flags poor outcomes in lung adenocarcinoma

Subscribe to Blog via Email

Enter your email address to subscribe to this blog and receive notifications of new posts by email.

Join 86 other subscribers
  • Contact Us

Bioengineer.org © Copyright 2023 All Rights Reserved.

Welcome Back!

Login to your account below

Forgotten Password?

Retrieve your password

Please enter your username or email address to reset your password.

Log In
No Result
View All Result
  • Homepages
    • Home Page 1
    • Home Page 2
  • News
  • National
  • Business
  • Health
  • Lifestyle
  • Science

Bioengineer.org © Copyright 2023 All Rights Reserved.